Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.48%||8.04||0.7%||$562.03m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.41%||506.48||2.7%||$449.94m|
|GILD||Gilead Sciences, Inc.||0.62%||66.79||1.0%||$433.53m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.18%||219.76||1.9%||$373.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.14%||168.44||2.0%||$372.56m|
|CRSP||CRISPR Therapeutics AG||2.68%||124.93||0.6%||$186.56m|
|NBIX||Neurocrine Biosciences, Inc.||0.91%||97.03||4.9%||$178.13m|
|EXAS||EXACT Sciences Corp.||2.49%||128.75||18.4%||$165.21m|
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.